| 42.45 1.68 (4.12%) | 09-08 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 54.91  |
1-year : | 64.14 |
| Resists | First : | 47.02 |
Second : | 54.91 |
| Pivot price | 38.45 |
|||
| Supports | First : | 40.14 |
Second : | 35.9 |
| MAs | MA(5) : | 40.25 |
MA(20) : | 38.49 |
| MA(100) : | 39.23 |
MA(250) : | 34.08 |
|
| MACD | MACD : | 0.1 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 97.7 |
D(3) : | 90.1 |
| RSI | RSI(14): 66.6 |
|||
| 52-week | High : | 47.02 | Low : | 23.13 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ GRDN ] has closed Bollinger Bands are 30.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 42.66 - 42.78 | 42.78 - 42.92 |
| Low: | 40.05 - 40.2 | 40.2 - 40.36 |
| Close: | 42.18 - 42.41 | 42.41 - 42.67 |
Guardian Pharmacy Services, Inc. operates as a pharmaceutical service provider, delivering an extensive array of tech-driven solutions. These services are specifically crafted to enhance the care of residents within long-term health care facilities (LTCFs) across the United States. The company specializes in offering personalized clinical assistance, efficient drug distribution, and comprehensive administrative support. These provisions are particularly beneficial for individuals in less acute long-term care environments, such as assisted living communities, behavioral health centers, and group homes. To bolster its operations, the company offers Guardian Compass, a platform that generates insightful dashboards from its extensive data warehouse. This tool enables its network of local pharmacies to effectively strategize, monitor performance, and refine their business processes. Furthermore, Guardian Pharmacy Services develops dedicated GuardianShield Programs for LTCFs. The company was established in 2003 and is based in Atlanta, Georgia.
Tue, 01 Sep 2026
Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy - Yahoo Finance
Sun, 09 Aug 2026
Earnings Beat: Guardian Pharmacy Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - simplywall.st
Sun, 09 Aug 2026
Guardian Pharmacy Services (GRDN) As Strong Results And Higher Outlook Recast The Valuation Story - Yahoo Finance
Sat, 08 Aug 2026
Why Guardian Pharmacy Services (GRDN) Is Up 10.9% After Raising 2026 Revenue Guidance And Expanding Footprint - Yahoo Finance
Thu, 06 Aug 2026
GRDN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 50 (M) |
| Shares Float | 32 (M) |
| Held by Insiders | 37.5 (%) |
| Held by Institutions | 60.7 (%) |
| Shares Short | 3,010 (K) |
| Shares Short P.Month | 2,790 (K) |
| EPS | 1.03 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.88 |
| Profit Margin | 4.5 % |
| Operating Margin | 3.4 % |
| Return on Assets (ttm) | 13.4 % |
| Return on Equity (ttm) | 30.4 % |
| Qtrly Rev. Growth | 2.2 % |
| Gross Profit (p.s.) | 6.35 |
| Sales Per Share | 29.31 |
| EBITDA (p.s.) | 2.19 |
| Qtrly Earnings Growth | 139.8 % |
| Operating Cash Flow | 99 (M) |
| Levered Free Cash Flow | 65 (M) |
| PE Ratio | 40.81 |
| PEG Ratio | 0 |
| Price to Book value | 10.94 |
| Price to Sales | 1.44 |
| Price to Cash Flow | 21.38 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|